Inmed Pharma Company Spotlight
Company Spotlight

Inmed Pharmaceuticals

Description: InMed Pharma (CSE: IN, OTCQB: IMLFF) is a clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. InMed’s proprietary platform technology, product pipeline and accelerated development pathway are the fundamental value drivers of the company.

Inmed Pharma WebsiteInmed Pharma LinkedInInmed Pharma Email

Recent News

November 16, 2017
InMed to Present at Cannabis-Based Science & Medicine Conference

November 14, 2017
InMed Reports No Material Change

October 24, 2017
InMed Announces Positive Pre-Clinical Data on an Ocular Hydrogel Formulation using a Biosynthesized Cannabinoid

Learn More

Want to learn more about InMed Pharmaceuticals?




Note: page will reload once form is submitted.

Get in touch

#340-200 Granville Street
Vancouver, BC
Canada V6C 1S4

Phone: (604) 669-7207
(604) 683-2506
Email: [email protected]

Mornings are better with Visual Capitalist.coffee_email1

Thank you!
Given email address is already subscribed, thank you!
Please provide a valid email address.
Please complete the CAPTCHA.
Oops. Something went wrong. Please try again later.